iSpecimen Inc. (ISPC) vs Revelation Biosciences, Inc. (REVB)
A side-by-side comparison of iSpecimen Inc. and Revelation Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ISPC
iSpecimen Inc.
$1.10HealthcareDelayed quote: Oct 6, 2026, 1:53 PM EDT
REVB
Revelation Biosciences, Inc.
$0.78HealthcareDelayed quote: Oct 6, 2026, 1:39 PM EDT
Total return — ISPC vs REVB
growth of $100 · dividends reinvested · last 5yISPC -100.0% (-82.1%/yr)REVB -100.0% (-93.5%/yr)ISPC compounded faster over this window
Log scale — wide-divergence pair
ISPC REVB
ISPC vs REVB: by the numbers
- •REVB is the larger company ($3M vs $3M market cap).
- •Both run net losses; REVB's is the smaller (0.00% vs -2449.04% net margin).
Metrics side by side
Valuation
| Metric | ISPC | REVB |
|---|---|---|
| P/S ratio | 5.94 | N/A |
| P/B ratio | 1.59 | 0.30 |
Profitability
| Metric | ISPC | REVB |
|---|---|---|
| Gross margin | 1.25% | 0.00% |
| Operating margin | -465.42% | 0.00% |
| Net margin | -2449.04% | 0.00% |
| ROE | -657.69% | -106.79% |
| ROIC | -476.39% | -104.28% |
Growth (annualized)
| Metric | ISPC | REVB |
|---|---|---|
| Revenue CAGR (5Y) | -46.70% | N/A |
| Total return CAGR (5Y) | -81.14% | -93.52% |
Frequently asked
- How have ISPC and REVB total returns compared?
- Over the past 5 years, ISPC delivered -81.14% and REVB delivered -93.52% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.